Hemogenyx Pharmaceuticals (HEMO) Stock Chart & Stock Price History GBX 580 +235.00 (+68.12%) As of 10:19 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock Hemogenyx Pharmaceuticals Stock Price Performance The Hemogenyx Pharmaceuticals (HEMO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 44,653.09%, with a year-to-date return of 44.28%. In the past month, the stock has increased 267.44%, reflecting recent market activity. As of the latest close, Hemogenyx Pharmaceuticals traded at GBX 341.50 with a market cap of £12.17 million and volume of 359,890 shares. Five years ago, the stock traded at GBX 14.40, representing a 3,927.78% increase over that period. At the time, it had a market cap of £62.44 million and a volume of 9.54 million shares. Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+232.95%1 Month Performance+267.44%3 Month Performance+226.81%Year-To-Date Performance+44.28%1 Year Performance+44,653.09%5 Year Performance+3,927.78% HEMO Stock Chart for Friday, August, 29, 2025 HEMO Chart by TradingView Hemogenyx Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/28/2025GBX 320GBX 341.50+6.72%GBX 370GBX 310359,890 shs£12.17 million08/27/2025GBX 187.50GBX 320+70.67%GBX 390GBX 185.50605,109 shs£11.41 million08/26/2025GBX 174.20GBX 187.50+7.63%GBX 198.88GBX 168.50293,329 shs£6.68 million08/25/2025GBX 174.20GBX 174.20GBX 179.41GBX 169.28163,479 shs£6.21 million08/22/2025GBX 169.75GBX 174.20+2.62%GBX 179.41GBX 169.28163,479 shs£6.21 million08/21/2025GBX 164.29GBX 169.75+3.32%GBX 173.58GBX 161.4278,245 shs£6.05 million08/20/2025GBX 159.50GBX 164.29+3.00%GBX 164.37GBX 15634,993 shs£5.86 million08/19/2025GBX 158.50GBX 159.50+0.63%GBX 159.50GBX 15131,419 shs£5.69 million08/18/2025GBX 150.38GBX 158.50+5.40%GBX 158.50GBX 150.1040,147 shs£5.65 million08/15/2025GBX 144.28GBX 150.38+4.23%GBX 158GBX 147.1586,992 shs£5.36 million Get the Latest News and Ratings for HEMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/14/2025GBX 134.66GBX 144.28+7.14%GBX 144.28GBX 134.2317,066 shs£5.14 million08/13/2025GBX 135.86GBX 134.66-0.88%GBX 141.50GBX 133.0539,189 shs£4.80 million08/12/2025GBX 141.90GBX 135.86-4.26%GBX 144.50GBX 135.8638,936 shs£4.84 million08/11/2025GBX 144.23GBX 141.90-1.62%GBX 148.50GBX 136.7830,047 shs£5.06 million08/08/2025GBX 142GBX 144.23+1.57%GBX 149.50GBX 142.8511,915 shs£5.14 million08/07/2025GBX 150.50GBX 142-5.65%GBX 152.50GBX 14222,226 shs£5.06 million08/06/2025GBX 143.56GBX 150.50+4.84%GBX 153GBX 141.5043,055 shs£5.37 million08/05/2025GBX 145GBX 143.56-1.00%GBX 145GBX 130105,751 shs£5.12 million08/04/2025GBX 156.49GBX 145-7.34%GBX 158.50GBX 142.4656,417 shs£5.17 million08/01/2025GBX 152.50GBX 156.49+2.62%GBX 157.13GBX 150.3814,272 shs£5.58 million07/31/2025GBX 159.50GBX 152.50-4.39%GBX 159.50GBX 152.503,164 shs£5.44 million07/30/2025GBX 157.85GBX 159.50+1.05%GBX 159.50GBX 152.853,715 shs£5.69 million07/29/2025GBX 167.75GBX 157.85-5.90%GBX 174.50GBX 152.5076,624 shs£5.63 million07/28/2025GBX 179.36GBX 167.75-6.47%GBX 183GBX 16642,995 shs£5.98 million Related Companies Arecor Therapeutics Stock Price Chart Poolbeg Pharma Stock Price Chart Aptamer Group Stock Price Chart Fusion Antibodies Stock Price Chart OptiBiotix Health Stock Price Chart IXICO Stock Price Chart Synairgen Stock Price Chart Oxford BioDynamics Stock Price Chart ImmuPharma Stock Price Chart Cizzle Biotechnology Stock Price Chart Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:HEMO) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemogenyx Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemogenyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.